The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
Dynamic of molecular subtypes of high‐grade serous ovarian cancer in paired primary and relapsed biopsies.
 
Elena Ioana Braicu
Honoraria - AstraZeneca; Clovis Oncology; CRA International; Incyte; Roche; Seagen; Tesaro
Consulting or Advisory Role - Clovis Oncology; CRA International; Roche Pharma AG; Seagen; Tesaro
Research Funding - Roche (Inst)
Travel, Accommodations, Expenses - AstraZeneca; Roche Pharma AG; Tesaro
 
Hagen Kulbe
No Relationships to Disclose
 
Felix Dreher
Employment - Alacris Theranostics
 
Eliane T Taube
No Relationships to Disclose
 
Frauke Ringel
No Relationships to Disclose
 
Gabriele Welsch
No Relationships to Disclose
 
Silvia Darb-Esfahani
No Relationships to Disclose
 
Carlotta Keunecke
No Relationships to Disclose
 
Thomas Kessler
Employment - Alacris Theranostics
Stock and Other Ownership Interests - Bayer; Gilead Sciences
 
Christoph Wierling
Employment - Alacris Theranostics
 
Paul Jank
No Relationships to Disclose
 
Carsten Denkert
Stock and Other Ownership Interests - Sividon Diagnostics
Honoraria - Amgen; Novartis; Pfizer; Roche; Teva
Consulting or Advisory Role - Amgen; Daiichi Sankyo; MSD Oncology
Patents, Royalties, Other Intellectual Property - EP20150702464 Patent application - therapy response; Patent application: EP18209672 - cancer immunotherapy; VMScope digital pathology software
 
Hedwig Lammert
No Relationships to Disclose
 
Michael Hummel
No Relationships to Disclose
 
Jalid Sehouli
Honoraria - AstraZeneca; Clovis Oncology; Eisai; Johnson & Johnson; MSD Oncology; Olympus Medical Systems; Pfizer; PharmaMar; Tesaro; Teva
Consulting or Advisory Role - AstraZeneca; Clovis Oncology; Lilly; Merck; MSD Oncology; Pfizer; PharmaMar; Tesaro
Research Funding - AstraZeneca (Inst); Bayer (Inst); Clovis Oncology (Inst); Merck (Inst); MSD Oncology (Inst); Pfizer (Inst); PharmaMar (Inst); Tesaro (Inst)
Travel, Accommodations, Expenses - AstraZeneca; Clovis Oncology; MSD Oncology; PharmaMar; Roche Pharma AG; Tesaro; Tesaro